Long-term Use of Daclizumab Safe, With Caveats

Although the open-label extension study of 1500 patients with MS showed relatively positive safety results for daclizumab, investigators urge caution for those with elevated liver enzymes.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply